These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35087757)

  • 1. Comprehensive Analysis of Cell Cycle-Related Genes in Patients With Prostate Cancer.
    Liu Z; Pan R; Li W; Li Y
    Front Oncol; 2021; 11():796795. PubMed ID: 35087757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma.
    Yao K; Zhang R; Li L; Liu M; Feng S; Yan H; Zhang Z; Xie D
    Front Immunol; 2023; 14():1181370. PubMed ID: 37600770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes.
    Jiang W; Xu J; Liao Z; Li G; Zhang C; Feng Y
    Front Cell Dev Biol; 2021; 9():655950. PubMed ID: 33869220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
    Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
    Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer.
    Yang C; Chen L; Niu Q; Ge Q; Zhang J; Tao J; Zhou J; Liang C
    Cancer Cell Int; 2022 Dec; 22(1):382. PubMed ID: 36471446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A N
    Mei W; Jia X; Xin S; Liu X; Jin L; Sun X; Zhang JX; Zhang B; Yang G; Chen P; Ye L
    J Oncol; 2022; 2022():8604216. PubMed ID: 35602299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An endoplasmic reticulum stress-related signature featuring ASNS for predicting prognosis and immune landscape in prostate cancer.
    Wu Z; Wu Z; Zeng J; Liu Y; Wang Y; Li H; Xia T; Liu W; Lin Z; Xu W
    Aging (Albany NY); 2024 Jan; 16(1):43-65. PubMed ID: 38206293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma.
    Zhuo X; Dai H; Yu S
    Medicine (Baltimore); 2022 Dec; 101(50):e31290. PubMed ID: 36550819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
    Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
    Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Signature and Therapeutic Value of Phagocytic Regulatory Factors in Prostate Adenocarcinoma (PRAD).
    Xin S; Sun X; Jin L; Li W; Liu X; Zhou L; Ye L
    Front Genet; 2022; 13():877278. PubMed ID: 35706452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of m5C RNA Modification Patterns in Biochemical Recurrence and Tumor Microenvironment Characterization of Prostate Adenocarcinoma.
    Xu Z; Chen S; Zhang Y; Liu R; Chen M
    Front Immunol; 2022; 13():869759. PubMed ID: 35603206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the Cancer Gene Atlas.
    Zhao X; Hu D; Li J; Zhao G; Tang W; Cheng H
    Biomed Res Int; 2020; 2020():5019793. PubMed ID: 32509861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.
    Zhang D; Zhang M; Zhang Q; Zhao Z; Nie Y
    Med Sci Monit; 2020 Jul; 26():e924543. PubMed ID: 32735556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gleason Score-related MT1L as biomarker for prognosis in prostate adenocarcinoma and contribute to tumor progression in vitro.
    Liu L; Li Y; Tang S; Yang B; Zhang Q; Xiao R; Hou X; Liu C; Ma L
    Int J Biol Markers; 2023 Jun; 38(2):114-123. PubMed ID: 37192745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of metabolism-associated molecular patterns in prostate cancer.
    Yang B; Jiang Y; Yang J; Zhou W; Yang T; Zhang R; Xu J; Guo H
    BMC Urol; 2023 Jun; 23(1):104. PubMed ID: 37280589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA profile study identifies an immune-related lncRNA prognostic signature for prostate adenocarcinoma.
    Liang L; Xia W; Yao L; Wu Q; Hua L; Cheng G; Wang Z; Zhao R
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108267. PubMed ID: 34740081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel circadian cycle-related gene signature for prognosis prediction of patients with breast cancer.
    Hu Y; Fan S; Zhu Y; Xie X
    Medicine (Baltimore); 2023 May; 102(18):e33718. PubMed ID: 37144994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2 as an independent predictor of poor prognosis promotes the migration via the PI3K/AKT axis in prostate cancer.
    Gao HT; Yang Z; Sun H; Zhang Y; Wang Z; Liu WY; Wen HZ; Qu CB; Wang XL
    Am J Transl Res; 2023; 15(2):779-798. PubMed ID: 36915769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer.
    Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D
    J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.